Article Type
Original Article
Section/Category
Oral and Maxillofacial Surgery
Abstract
Purpose: To evaluate, both clinically and radiographically, the use of extended platelet-rich fibrin versus a pericardium membrane in mandibular ridge splitting accompanied by immediate implant placement.
Materials and Methods: A total of sixteen implants were placed in eight patients with horizontally atrophic posterior mandibular ridges measuring 3–6 mm in width were randomly assigned to two groups with equal numbers. Both groups underwent ridge splitting with simultaneous implant insertion. In Group I, the intercortical defect was grafted with bone allograft and covered using a pericardium membrane, while Group II received extended platelet-rich fibrin (e-PRF) membrane instead. Clinical assessment focused on assessment of implant stability through resonance frequency analysis and radiographic examination with CBCT was performed to measure alveolar ridge width, bone gain, and bone loss.
Results: Immediate postoperative assessment showed that alveolar ridge width increased significantly in both groups. Despite this improvement, there were no statistically significant differences between the two groups regarding implant stability, ridge width measurements, bone gain, or bone resorption (p > 0.05).
Conclusion: Extended platelet-rich fibrin provided clinical and radiographic outcomes comparable to a pericardium membrane in mandibular alveolar ridge splitting procedures. e-PRF may be considered a biological alternative for commercially available pericardium membranes.
Keywords
Ridge splitting; Extended platelet-rich fibrin; Bone allograft; pericardium membrane; simultaneous implant placement
How to Cite This Article
Alshammary F , Elsheikh H , Al-Zordk W , Mansour N .
Extended Platelet Rich Fibrin in Mandibular Alveolar Ridge Splitting with Simultaneous Implant Placement.
Mans J Dent.
2026;
13(2):
Available at:
https://doi.org/10.61793/2812-5479.1188
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-No Derivative Works 4.0 International License.
